Robert J. Capetola

1.0k total citations
40 papers, 830 citations indexed

About

Robert J. Capetola is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Robert J. Capetola has authored 40 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pharmacology and 10 papers in Immunology. Recurrent topics in Robert J. Capetola's work include Inflammatory mediators and NSAID effects (9 papers), Retinoids in leukemia and cellular processes (7 papers) and Skin Protection and Aging (4 papers). Robert J. Capetola is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Retinoids in leukemia and cellular processes (7 papers) and Skin Protection and Aging (4 papers). Robert J. Capetola collaborates with scholars based in United States, Italy and Canada. Robert J. Capetola's co-authors include Marvin E. Rosenthale, James A. Mezick, Gerard J. Gendimenico, J.L. McGuire, Dennis Argentieri, M E Kahn, David M. Ritchie, Riva Eichner, Thomas Kirchner and Barry Dubinsky and has published in prestigious journals such as Nucleic Acids Research, The Journal of Immunology and Journal of Medicinal Chemistry.

In The Last Decade

Robert J. Capetola

40 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Capetola United States 18 224 176 144 132 119 40 830
John M. Yanni United States 23 246 1.1× 200 1.1× 199 1.4× 136 1.0× 497 4.2× 52 1.6k
Yasuhide Morioka Japan 19 392 1.8× 201 1.1× 193 1.3× 71 0.5× 110 0.9× 50 973
Crystal A. Leslie United States 14 310 1.4× 215 1.2× 194 1.3× 21 0.2× 145 1.2× 24 971
Zdeňka Hořáková United States 14 257 1.1× 187 1.1× 207 1.4× 141 1.1× 412 3.5× 22 1.1k
Mildred A. Donlon United States 11 268 1.2× 56 0.3× 129 0.9× 37 0.3× 276 2.3× 22 708
A. Schmal Germany 17 357 1.6× 124 0.7× 115 0.8× 75 0.6× 193 1.6× 56 988
J A Lindgren Sweden 8 315 1.4× 262 1.5× 513 3.6× 35 0.3× 373 3.1× 8 1.3k
W. Schmutzler Germany 15 307 1.4× 82 0.5× 220 1.5× 21 0.2× 351 2.9× 99 833
B S Tsai United States 19 565 2.5× 186 1.1× 377 2.6× 26 0.2× 160 1.3× 37 1.1k
Frances A. Emig United States 14 342 1.5× 100 0.6× 161 1.1× 13 0.1× 191 1.6× 17 887

Countries citing papers authored by Robert J. Capetola

Since Specialization
Citations

This map shows the geographic impact of Robert J. Capetola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Capetola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Capetola more than expected).

Fields of papers citing papers by Robert J. Capetola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Capetola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Capetola. The network helps show where Robert J. Capetola may publish in the future.

Co-authorship network of co-authors of Robert J. Capetola

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Capetola. A scholar is included among the top collaborators of Robert J. Capetola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Capetola. Robert J. Capetola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eichner, Riva, Gerard J. Gendimenico, M E Kahn, et al.. (1996). Effects of long-term retinoic acid treatment on epidermal differentiation in vivo: specific modifications in the programme of terminal differentiation. British Journal of Dermatology. 135(5). 687–695. 24 indexed citations
2.
Pope, Barbara L., et al.. (1993). Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.. The Journal of Immunology. 151(6). 3007–3017. 15 indexed citations
3.
Ritchie, David M., Thomas Kirchner, John B. Moore, et al.. (1993). Experimental Antiasthmatic Activity of RWJ 22108: A Bronchoselective Calcium Entry Blocker. International Archives of Allergy and Immunology. 100(3). 274–282. 3 indexed citations
4.
Pope, Barbara L., et al.. (1993). In Vivo Activation of Natural Killer Cells and Priming of IL-2 Responsive Cytolytic Cells by Loxoribine (7-Allyl-8-oxoguanosine). Cellular Immunology. 147(2). 302–312. 11 indexed citations
5.
Pope, Barbara L., et al.. (1992). In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine). International Journal of Immunopharmacology. 14(8). 1375–1382. 13 indexed citations
6.
Kligman, L. H., James A. Mezick, Robert J. Capetola, & E. George Thorne. (1992). Lifetime topical application of tretinoin to hairless mice.. Acta Dermato Venereologica. 72(6). 418–422. 6 indexed citations
7.
Wallace, John L., Giuseppe Cirino, Carla Cicala, et al.. (1991). Comparison of the ulcerogenic properties of tepoxalin with those of non-steroidal anti-inflammatory drugs (NSAIDs). Inflammation Research. 34(1-2). 247–250. 15 indexed citations
8.
Goodman, Michael, Sudhir Gupta, Marvin E. Rosenthale, et al.. (1991). Protein kinase C independent restoration of specific immune responsiveness in common variable immunodeficiency. Clinical Immunology and Immunopathology. 59(1). 26–36. 7 indexed citations
9.
Demarest, Keith T., et al.. (1989). Profile of an Oxytocin Antagonist, RWJ 22164 for Treatment of Preterm Labor in Laboratory Models of Uterine Contractility. American Journal of Perinatology. 6(2). 200–204. 18 indexed citations
10.
Mezick, James A., et al.. (1989). Topical all-trans-retinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect. Journal of the American Academy of Dermatology. 21(2). 186–190. 43 indexed citations
11.
Phillips, A., D.W. Hahn, J.L. McGuire, et al.. (1988). Evaluation of the anaphylactoid activity of a new LHRH antagonist. Life Sciences. 43(11). 883–888. 19 indexed citations
12.
Phillips, A., et al.. (1987). Anaphylactoid and anti-ovulatory activities of LHRH antagonists in rats. Life Sciences. 41(17). 2017–2022. 4 indexed citations
13.
Hahn, D.W., et al.. (1987). Evaluation of 1-deamino-[D-Tyr(Oethyl)2, Thr4, Orn8] vasotocin, an oxytocin antagonist in animal models of uterine contractility and preterm labor: A new tocolytic agent. American Journal of Obstetrics and Gynecology. 157(4). 977–982. 29 indexed citations
14.
Heyner, Susan, et al.. (1986). Humokal and Cellulaa Immunologic Aspects of Adjuvant and Collagfn Arthritis in Rats. Immunopharmacology and Immunotoxicology. 8(3). 347–370. 10 indexed citations
15.
Otterness, Ivan G., et al.. (1984). Therapeutic control of inflammatory diseases. Raven Press eBooks. 1 indexed citations
16.
Tolman, E.L., Marvin E. Rosenthale, Robert J. Capetola, & J.L. McGuire. (1984). Suprofen: the Pharmacology and Clinical Efficacy of a New Non-narcotic Peripheral Analgesic. Clinics in Rheumatic Diseases. 10(2). 353–368. 10 indexed citations
17.
Capetola, Robert J., J.L. McGuire, & Marvin E. Rosenthale. (1983). Introduction to the Pharmacology of Suprofen. Pharmacology. 27(1). 1–13. 11 indexed citations
18.
Rosenthale, Marvin E. & Robert J. Capetola. (1982). Adjuvant arthritis: immunopathological and hyperalgesic features.. PubMed. 41(9). 2577–82. 39 indexed citations
19.
Ritchie, David M., et al.. (1981). SRSA-mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo. Inflammation Research. 11(4). 396–401. 40 indexed citations
20.
Capetola, Robert J., et al.. (1980). Suprofen, a new peripheral analgesic.. Journal of Pharmacology and Experimental Therapeutics. 214(1). 16–23. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Yanni Breakdown of academic impact, for papers by Yasuhide Morioka Breakdown of academic impact, for papers by Crystal A. Leslie Breakdown of academic impact, for papers by Zdeňka Hořáková Breakdown of academic impact, for papers by Mildred A. Donlon Breakdown of academic impact, for papers by A. Schmal Breakdown of academic impact, for papers by J A Lindgren Breakdown of academic impact, for papers by W. Schmutzler Breakdown of academic impact, for papers by B S Tsai Breakdown of academic impact, for papers by Frances A. Emig
Rankless by CCL
2026